论文部分内容阅读
2017年第三季度,拜耳集团在战略和运营方面取得了更深一步的发展。“上一季度,我们采取了一些重要的战略举措。”管理委员会主席沃纳·保曼(Werner Baumann)在最近发布的第三季度中期报告中表示,拜耳在实现其目标(即在中期实现科思创的完全剥离)过程中已经取得了显著的进展。谈到拟议的收购孟山都交易,保曼解释,与巴斯夫签署协议,将部分作物科学业务出售给巴斯夫,这标志着拜耳又迈出
The third quarter of 2017, Bayer Group has made further strategic and operational development. “In the last quarter, we took some important strategic moves.” Management Board Chairman Werner Baumann said in a recently released third quarter interim report that Bayer is achieving its goal (that is, in the medium term Achieve complete stripping Covestr) process has made significant progress. Commenting on the proposed acquisition of Monsanto, Paul Baman explained that it had signed an agreement with BASF to sell part of the crop science business to BASF, which marks the beginning of Bayer’s move